We've rounded up seven student projects featured in Dezeen School Shows that utilise modern technology to innovate medical ...

Enrollment of Part A completed ahead of schedule and exceeded enrollment target with 123 patients enrolledPart A 16-week proof-of-concept data ...

Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

The Brazilian Health Regulatory Agency (ANVISA) granted approval for the FlareHawk7 and FlareHawk9 spine implant devices.

Apogee begins patient dosing in Part B of phase 2 APEX trial of APG777 to treat moderate-to-severe atopic dermatitis: San Francisco Tuesday, February 4, 2025, 18:00 Hrs [IST] Apog ...

PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...

Johnson & Johnson has launched the TECNIS PureSee™ intraocular lens in India, catering to individuals with presbyopia. The ...

Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results in Friedreich's ataxia. See more here.

Join us as we gather the world's top young leaders, founders and creators for four days of connecting, learning, teaching and building in our new host city of ...

Contributor content. As a health care IT specialist, Vedamurthy Yogeshappa uses Artificial Intelligence (AI) to streamline ...

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

Roflumilast demonstrated effectiveness and safety in treating psoriasis, with added benefits for patients with comorbidities.